Our work is performed by a group of laboratory professionals and hematopathologists.
Through the experience and knowledge we have gained in the last 20 years of working and continually training in highly recognized laboratories in United States (Shands Hospital, University of Florida, Gainesville, FL; Hematologics.Inc (Seattle, WA) and Spain (Servicio General de Citometria de Flujo, Universidad de Salamanca), we possess unique skills to provide high quality data analysis services.
Interpflow has been providing services in the last 15 years to clinical laboratories, clinical researchers and hematopathology departments.
We currently provide remote flow data analysis to:
* Clinical Flow Cytometry Laboratory, Laboratory of Pathology, National Cancer Institute, National Institutes of Health (LP/NCI/NIH), since 2007.
* Hematology Laboratory, Department of Laboratory Medicine, Clinical Center, National Institutes of Health (DLM/CC/NIH), since 2017.
For each individual customer, we are able to accommodate our service to their individual needs, ensuring efficient performance, uninterrupted service, and the highest level of security. After contract agreement is established, we personally visit the customer facility.
Flow cytometry is a method applied in reference, specialized laboratories as a useful ancillary tool for diagnosis of hematologic neoplasia in blood / bone marrow and lymph nodes (Leukemias and Lymphomas).
Interpflow provides remote analysis of flow cytometry data/list mode files generated by flow cytometry laboratories in USA.
Flow cytometry list mode data files transfer: through a secure network connection (VPN or similar).
Data analysis: performed using FCS Express 7 (DeNovo) and Infincyt (Cytognos).
Flow cytometry analysis templates, including unsigned interpretation of flow data results and signed by pathologists to complete clinical case evaluation.
Clinical relevance of Immunophenotyping by Flow Cytometry in hematological malignancies (1).
For more than two decades, Immunophenotyping provides relevant information for the diagnosis, classification and monitoring of hematological malignancies.
Together with cyto/histomorphology and molecular (cyto)genetics, immunophenotyping is crucial for the identification, enumeration and characterization of leukemia and lymphoma cells.
Consequently, immunophenotyping has acquired a prominent position in the current World Health Organization (WHO) classification of hematological malignancies (2, 3, 4)